Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Long-acting Injectable Medications Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application

Request for Sample of this report
Buy now

1 Market Overview of Long-acting Injectable Medications

  • 1.1 Long-acting Injectable Medications Market Overview
    • 1.1.1 Long-acting Injectable Medications Product Scope
    • 1.1.2 Market Status and Outlook
  • 1.2 Global Long-acting Injectable Medications Market Size Overview by Region 2015 VS 2020 VS 2026
  • 1.3 Global Long-acting Injectable Medications Market Size by Region (2015-2026)
  • 1.4 Global Long-acting Injectable Medications Historic Market Size by Region (2015-2020)
  • 1.5 Global Long-acting Injectable Medications Market Size Forecast by Region (2021-2026)
  • 1.6 Key Regions, Long-acting Injectable Medications Market Size YoY Growth (2015-2026)
    • 1.6.1 North America Long-acting Injectable Medications Market Size YoY Growth (2015-2026)
    • 1.6.2 Europe Long-acting Injectable Medications Market Size YoY Growth (2015-2026)
    • 1.6.3 Asia-Pacific Long-acting Injectable Medications Market Size YoY Growth (2015-2026)
    • 1.6.4 Latin America Long-acting Injectable Medications Market Size YoY Growth (2015-2026)
    • 1.6.5 Middle East & Africa Long-acting Injectable Medications Market Size YoY Growth (2015-2026)

2 Long-acting Injectable Medications Market Overview by Type

  • 2.1 Global Long-acting Injectable Medications Market Size by Type: 2015 VS 2020 VS 2026
  • 2.2 Global Long-acting Injectable Medications Historic Market Size by Type (2015-2020)
  • 2.3 Global Long-acting Injectable Medications Forecasted Market Size by Type (2021-2026)
  • 2.4 First-generation
  • 2.5 Second-generation

3 Long-acting Injectable Medications Market Overview by Application

  • 3.1 Global Long-acting Injectable Medications Market Size by Application: 2015 VS 2020 VS 2026
  • 3.2 Global Long-acting Injectable Medications Historic Market Size by Application (2015-2020)
  • 3.3 Global Long-acting Injectable Medications Forecasted Market Size by Application (2021-2026)
  • 3.4 Schizophrenia
  • 3.5 Contraception
  • 3.6 HIV
  • 3.7 Others

4 Global Long-acting Injectable Medications Competition Analysis by Players

  • 4.1 Global Long-acting Injectable Medications Market Size by Players (2015-2020)
  • 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-acting Injectable Medications as of 2019)
  • 4.3 Date of Key Manufacturers Enter into Long-acting Injectable Medications Market
  • 4.4 Global Top Players Long-acting Injectable Medications Headquarters and Area Served
  • 4.5 Key Players Long-acting Injectable Medications Product Solution and Service
  • 4.6 Competitive Status
    • 4.6.1 Long-acting Injectable Medications Market Concentration Rate
    • 4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data

  • 5.1 Eli Lilly
    • 5.1.1 Eli Lilly Profile
    • 5.1.2 Eli Lilly Main Business
    • 5.1.3 Eli Lilly Long-acting Injectable Medications Products, Services and Solutions
    • 5.1.4 Eli Lilly Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
    • 5.1.5 Eli Lilly Recent Developments
  • 5.2 Alkermes
    • 5.2.1 Alkermes Profile
    • 5.2.2 Alkermes Main Business
    • 5.2.3 Alkermes Long-acting Injectable Medications Products, Services and Solutions
    • 5.2.4 Alkermes Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
    • 5.2.5 Alkermes Recent Developments
  • 5.3 Johnson & Johnson
    • 5.5.1 Johnson & Johnson Profile
    • 5.3.2 Johnson & Johnson Main Business
    • 5.3.3 Johnson & Johnson Long-acting Injectable Medications Products, Services and Solutions
    • 5.3.4 Johnson & Johnson Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
    • 5.3.5 Zogenix Recent Developments
  • 5.4 Zogenix
    • 5.4.1 Zogenix Profile
    • 5.4.2 Zogenix Main Business
    • 5.4.3 Zogenix Long-acting Injectable Medications Products, Services and Solutions
    • 5.4.4 Zogenix Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
    • 5.4.5 Zogenix Recent Developments
  • 5.5 DURECT
    • 5.5.1 DURECT Profile
    • 5.5.2 DURECT Main Business
    • 5.5.3 DURECT Long-acting Injectable Medications Products, Services and Solutions
    • 5.5.4 DURECT Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
    • 5.5.5 DURECT Recent Developments
  • 5.6 Mapi Pharma
    • 5.6.1 Mapi Pharma Profile
    • 5.6.2 Mapi Pharma Main Business
    • 5.6.3 Mapi Pharma Long-acting Injectable Medications Products, Services and Solutions
    • 5.6.4 Mapi Pharma Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
    • 5.6.5 Mapi Pharma Recent Developments
  • 5.7 GSK
    • 5.7.1 GSK Profile
    • 5.7.2 GSK Main Business
    • 5.7.3 GSK Long-acting Injectable Medications Products, Services and Solutions
    • 5.7.4 GSK Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
    • 5.7.5 GSK Recent Developments
  • 5.8 MedinCell
    • 5.8.1 MedinCell Profile
    • 5.8.2 MedinCell Main Business
    • 5.8.3 MedinCell Long-acting Injectable Medications Products, Services and Solutions
    • 5.8.4 MedinCell Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
    • 5.8.5 MedinCell Recent Developments
  • 5.9 Oakwood Labs
    • 5.9.1 Oakwood Labs Profile
    • 5.9.2 Oakwood Labs Main Business
    • 5.9.3 Oakwood Labs Long-acting Injectable Medications Products, Services and Solutions
    • 5.9.4 Oakwood Labs Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
    • 5.9.5 Oakwood Labs Recent Developments
  • 5.10 Nanomi
    • 5.10.1 Nanomi Profile
    • 5.10.2 Nanomi Main Business
    • 5.10.3 Nanomi Long-acting Injectable Medications Products, Services and Solutions
    • 5.10.4 Nanomi Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
    • 5.10.5 Nanomi Recent Developments
  • 5.11 Pharmathen
    • 5.11.1 Pharmathen Profile
    • 5.11.2 Pharmathen Main Business
    • 5.11.3 Pharmathen Long-acting Injectable Medications Products, Services and Solutions
    • 5.11.4 Pharmathen Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
    • 5.11.5 Pharmathen Recent Developments
  • 5.12 Kashiv BioSciences
    • 5.12.1 Kashiv BioSciences Profile
    • 5.12.2 Kashiv BioSciences Main Business
    • 5.12.3 Kashiv BioSciences Long-acting Injectable Medications Products, Services and Solutions
    • 5.12.4 Kashiv BioSciences Long-acting Injectable Medications Revenue (US$ Million) & (2015-2020)
    • 5.12.5 Kashiv BioSciences Recent Developments

6 North America

  • 6.1 North America Long-acting Injectable Medications Market Size by Country
  • 6.2 United States
  • 6.3 Canada

7 Europe

  • 7.1 Europe Long-acting Injectable Medications Market Size by Country
  • 7.2 Germany
  • 7.3 France
  • 7.4 U.K.
  • 7.5 Italy
  • 7.6 Russia
  • 7.7 Nordic
  • 7.8 Rest of Europe

8 Asia-Pacific

  • 8.1 Asia-Pacific Long-acting Injectable Medications Market Size by Region
  • 8.2 China
  • 8.3 Japan
  • 8.4 South Korea
  • 8.5 Southeast Asia
  • 8.6 India
  • 8.7 Australia
  • 8.8 Rest of Asia-Pacific

9 Latin America

  • 9.1 Latin America Long-acting Injectable Medications Market Size by Country
  • 9.2 Mexico
  • 9.3 Brazil
  • 9.4 Rest of Latin America

10 Middle East & Africa

  • 10.1 Middle East & Africa Long-acting Injectable Medications Market Size by Country
  • 10.2 Turkey
  • 10.3 Saudi Arabia
  • 10.4 UAE
  • 10.5 Rest of Middle East & Africa

11 Long-acting Injectable Medications Market Dynamics

  • 11.1 Industry Trends
  • 11.2 Market Drivers
  • 11.3 Market Challenges
  • 11.4 Market Restraints

12 Research Finding /Conclusion

    13 Methodology and Data Source

    • 13.1 Methodology/Research Approach
      • 13.1.1 Research Programs/Design
      • 13.1.2 Market Size Estimation
      • 13.1.3 Market Breakdown and Data Triangulation
    • 13.2 Data Source
      • 13.2.1 Secondary Sources
      • 13.2.2 Primary Sources
    • 13.3 Disclaimer

    Long-acting injectables (LAIs) are unique tools used in psychiatric pharmacy to help improve patient outcomes. They offer a number of benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability and prevention of antipsychotic overdoses. Its origins in indications such as schizophrenia and contraception, also HIV treatment and prevention.

    Market Analysis and Insights: Global Long-acting Injectable Medications Market
    The research report studies the Long-acting Injectable Medications market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
    The global Long-acting Injectable Medications market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
    Global Long-acting Injectable Medications Scope and Segment
    The global Long-acting Injectable Medications market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Long-acting Injectable Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
    by Type, the market is primarily split into
    First-generation
    Second-generation
    by Application, this report covers the following segments
    Schizophrenia
    Contraception
    HIV
    Others
    Global Long-acting Injectable Medications market: regional analysis, the major regions covered in the report are:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa
    The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
    The Long-acting Injectable Medications key players in this market include:
    Eli Lilly
    Alkermes
    Johnson & Johnson
    Zogenix
    DURECT
    Mapi Pharma
    GSK
    MedinCell
    Oakwood Labs
    Nanomi
    Pharmathen
    Kashiv BioSciences
    Buy now